Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms
Yıl: 2020 Cilt: 16 Sayı: 2 Sayfa Aralığı: 155 - 157 Metin Dili: İngilizce DOI: 10.5152/ejbh.2020.5339 İndeks Tarihi: 22-11-2020
Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Cancer Research UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer#headingThree. Accessed August 2019.
- 2. Cancer Research UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer. Accessed August 2019.
- 3. NICE guidelines CG101. Early and locally advanced breast cancer: diagnosis and management. Published July 2018. https://www.nice. org.uk/guidance/ng101/chapter/Finding-more-information-and-resources
- 4. NICE guidelines CG164. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. Published June 2013. Last updated March 2017. https:// www.nice.org.uk/guidance/cg164
- 5. NICE guidelines [NG23]. Menopause: diagnosis and management. Published November 2015. https://www.nice.org.uk/guidance/NG23
- 6. Tanna N, Woyka J, Abernethy K, Reichert R, Pitkin J. A joint specialist breast cancer and menopause symptoms (BCMS) clinic: Service development using a clinical governance approach. Eur J Surg Oncol 2009; 35: 1242. [CrossRef]
- 7. Tanna N, Buijs H, Longmate M, Pitkin J. Specialist Menopause Care for Breast Cancer Survivors. 6th Amsterdam Menopause & Womens Health Symposium 2010; 120-121.
- 8. Woyka J, Pitkin J, Tanna N, Abernethy K. Establishing a dedicated menopause service for women with breast cancer or at high risk from breast cancer. Maturitas 2009; 63: S54. [CrossRef]
- 9. Tanna N, Pop A, Pitkin J. Prescribing of non-hormonal therapies within a joint specialist breast cancer and menopause symptoms (BCMS) clinic. Maturitas 2009; 63: S53. [CrossRef]
- 10. Pop A, Tanna N, Pitkin J. Breast cancer patient case study - prescribing of gabapentin for vasomotor symptom control and supporting patient compliance / concordance. Maturitas 2009; 63: S53. [CrossRef]
- 11. Woyka J, Tanna N, Abernethy K, Reichert R, Pitkin J. A menopause service for women with breast cancer or at high risk from breast cancer. Eur J Surg Oncol 2009; 35(: 1226-1227. [CrossRef]
- 12. Tanna N, Woyka J, Abernethy K, Reichert R, Pitkin J. A joint specialist breast cancer and menopause symptoms (BSMS) clinic: Service development using a clinical governance approach. 6th Amsterdam Menopause and Women's Health Symposium 2010, 119.
- 13. Tanna N, Batten C, Pitkin J. Audit of breast cancer patients on Aromatase Inhibitors with baseline DEXA scans. Osteoporosis Int 2010; 21: S481.
- 14. Tanna N, Buijs H, Pitkin J. Exploring the breast cancer patient journey: do breast cancer survivors need menopause management support? Menopause Int 2011; 17: 126-130. [CrossRef]
- 15. Tanna N, Buijs H, Pitkin J, Reichert R. Breast cancer patient stories project. Menopause Int 2012; 18: 128-133. (PMid:23081974) [CrossRef]
- 16. Tanna N, Shah D, Pitkin J. Support for menopause symptoms in Indian women with breast cancer. 9th European Congress on Menopause and Andropause. Maturitas 2012; 71(Suppl 1): S33. [CrossRef]
| APA | Tanna N, Kadoglou N, FUSI L (2020). Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. , 155 - 157. 10.5152/ejbh.2020.5339 |
| Chicago | Tanna Nuttan,Kadoglou Naim,FUSI Luca Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. (2020): 155 - 157. 10.5152/ejbh.2020.5339 |
| MLA | Tanna Nuttan,Kadoglou Naim,FUSI Luca Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. , 2020, ss.155 - 157. 10.5152/ejbh.2020.5339 |
| AMA | Tanna N,Kadoglou N,FUSI L Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. . 2020; 155 - 157. 10.5152/ejbh.2020.5339 |
| Vancouver | Tanna N,Kadoglou N,FUSI L Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. . 2020; 155 - 157. 10.5152/ejbh.2020.5339 |
| IEEE | Tanna N,Kadoglou N,FUSI L "Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms." , ss.155 - 157, 2020. 10.5152/ejbh.2020.5339 |
| ISNAD | Tanna, Nuttan vd. "Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms". (2020), 155-157. https://doi.org/10.5152/ejbh.2020.5339 |
| APA | Tanna N, Kadoglou N, FUSI L (2020). Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. European Journal of Breast Health, 16(2), 155 - 157. 10.5152/ejbh.2020.5339 |
| Chicago | Tanna Nuttan,Kadoglou Naim,FUSI Luca Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. European Journal of Breast Health 16, no.2 (2020): 155 - 157. 10.5152/ejbh.2020.5339 |
| MLA | Tanna Nuttan,Kadoglou Naim,FUSI Luca Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. European Journal of Breast Health, vol.16, no.2, 2020, ss.155 - 157. 10.5152/ejbh.2020.5339 |
| AMA | Tanna N,Kadoglou N,FUSI L Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. European Journal of Breast Health. 2020; 16(2): 155 - 157. 10.5152/ejbh.2020.5339 |
| Vancouver | Tanna N,Kadoglou N,FUSI L Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms. European Journal of Breast Health. 2020; 16(2): 155 - 157. 10.5152/ejbh.2020.5339 |
| IEEE | Tanna N,Kadoglou N,FUSI L "Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms." European Journal of Breast Health, 16, ss.155 - 157, 2020. 10.5152/ejbh.2020.5339 |
| ISNAD | Tanna, Nuttan vd. "Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms". European Journal of Breast Health 16/2 (2020), 155-157. https://doi.org/10.5152/ejbh.2020.5339 |
